RxDoctor Payments Data

Melissa Gulosh, DPM

Foot & Ankle Surgery · Fredericksburg, VANPI 1104266220

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2022 at $4,484 and has fallen 85.5% since, to $648 in 2025.

$10,429in general payments, 2019–2025

Across 235 payments — averaging $44.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Arthrex$2K
  • Arteriocyte Medical Systems, Inc.$2K
  • Organogenesis Inc.$642
  • Smith+Nephew$536
  • Fortis Surgical, LLC$451
  • plus $2K from 32 others

What the payments were for

  • Travel & lodging$4,04039%
  • Food & beverage$5,18950%
  • Education$1,20012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,429 in reported general payments places this provider in the 75th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$422,969
Medicare patients
300
Services billed
2,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin41$258
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$138
Levofloxacin11$112
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$74
Silver Sulfadiazine18$56

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →